Researchers studied five-year survival and baseline clinical variables in 105,612 Medicare beneficiaries aged 66 and older who received either multivessel CABG or multivessel PCI between 1992 and 2008. Patient age averaged 75; 42 percent were women, 92 percent were white and 33 percent were diabetic.
Five-year survival was 74.7 percent after CABG and 71.8 percent after PCI, but survival rates were significantly higher for CABG versus PCI in patients with diabetes, heart failure or peripheral vascular disease, as well as in smokers.
Related Articles on Mortality:
Comorbidities Increase Risk of Mortality in COPD Patient
ICU Hospitalist Model May Improve LOS, Infection Rates, Costs and Patient Satisfaction
5 Strategies to Improve Mortality for Heart Attack Cases
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
